{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:50:49Z","timestamp":1762102249491,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.07.010","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T19:09:29Z","timestamp":1532113769000},"page":"5166-5172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost"],"prefix":"10.1016","volume":"36","author":[{"given":"Konstantin","family":"Virnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Nesti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Dail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Scanlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Medvedev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Vassell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas","family":"Stamatatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Berkower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.010_b0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2010.09.011","article-title":"Induction of immunity to human immunodeficiency virus type-1 by vaccination","volume":"33","author":"McElrath","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.07.010_b0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni.3158","article-title":"Antibody responses to envelope glycoproteins in HIV-1 infection","volume":"16","author":"Burton","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.07.010_b0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2015.03.004","article-title":"Maturation and diversity of the VRC01-antibody lineage over 15 years of chronic HIV-1 infection","volume":"161","author":"Wu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2018.07.010_b0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.07.010_b0030","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/jvi.67.11.6642-6647.1993","article-title":"A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1","volume":"67","author":"Muster","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0035","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","article-title":"The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120","volume":"76","author":"Sanders","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0040","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1016\/j.vaccine.2012.06.074","article-title":"Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers","volume":"30","author":"Virnik","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.010_b0045","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.vaccine.2013.02.055","article-title":"Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions","volume":"31","author":"Virnik","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.010_b0050","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.20122824","article-title":"Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies","volume":"210","author":"McGuire","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.07.010_b0055","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.vaccine.2017.04.047","article-title":"Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors","volume":"35","author":"Virnik","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.010_b0060","series-title":"Vaccines","first-page":"688","article-title":"Rubella Vaccine","author":"Plotkin","year":"2013"},{"key":"10.1016\/j.vaccine.2018.07.010_b0065","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.vaccine.2015.02.067","article-title":"Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques","volume":"33","author":"Rosati","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.010_b0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-4690-10-99","article-title":"Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques","volume":"10","author":"Virnik","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2018.07.010_b0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/aid.1994.10.1651","article-title":"A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1","volume":"10","author":"Purtscher","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2018.07.010_b0080","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.07.010_b0085","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1213782","article-title":"Increasing the potency and breadth of an HIV antibody by using structure-based rational design","volume":"334","author":"Diskin","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.07.010_b0090","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/jvi.70.2.1100-1108.1996","article-title":"Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1","volume":"70","author":"Trkola","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0095","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"Stiegler","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2018.07.010_b0100","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1038\/ncomms10618","article-title":"Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice","volume":"7","author":"McGuire","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.07.010_b0105","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.celrep.2017.04.013","article-title":"Quantification of the impact of the HIV-1-glycan shield on antibody elicitation","volume":"19","author":"Zhou","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2018.07.010_b0110","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1128\/JVI.05391-11","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0115","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1128\/JVI.00239-07","article-title":"Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection","volume":"81","author":"Gray","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.07.010_b0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.07.010_b0130","doi-asserted-by":"crossref","first-page":"1237874","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.07.010_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01077-17","article-title":"HIV-1 gp120 and modified vaccinia virus ankara (MVA) gp140 boost immunogens increase immunogenicity of a DNA\/MVA HIV-1 vaccine","volume":"91","author":"Shen","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0140","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.vaccine.2009.01.057","article-title":"Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses","volume":"27","author":"Liniger","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.010_b0145","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1128\/JVI.00550-09","article-title":"Prime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques","volume":"83","author":"Xu","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b0150","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2005.05.034","article-title":"Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660","volume":"23","author":"Johnston","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.010_b0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virol.2014.01.017","article-title":"Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment","volume":"452\u2013453","author":"de Santana","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.07.010_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8848","article-title":"A randomized controlled safety\/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection","volume":"9","author":"Sneller","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.07.010_b0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.07.010_b0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.01515-07","article-title":"Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice","volume":"82","author":"Cooper","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.010_b9000","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41467-017-01336-3","article-title":"Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations","volume":"8","author":"Williams","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.07.010_b9005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.celrep.2015.03.047","article-title":"Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design","volume":"11","author":"Sharma","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2018.07.010_b9010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nsmb.3051","article-title":"Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env","volume":"22","author":"Kwon","year":"2015","journal-title":"Nat Struct Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830940X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830940X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:23Z","timestamp":1759400903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1830940X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X1830940X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}